Financial Results for Dec 31, 2010
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.12-02-2011
Financial Results for Dec 31, 2010
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.Lincoln Pharmaceuticals Ltd. introduces India's first Long-Acting Paracetamol 'Pa-12' for Long term relief from Fever and Pain
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 07, 2011 titled "Lincoln Pharmaceuticals Ltd. introduces India's first Long-Acting Paracetamol 'Pa-12' for Long term relief from Fever and Pain"Press Release :"Lincoln Pharmaceuticals Limited (LPL), Ahmedabad based world class pharmaceutical company recognized for manufacturing top class quality Health Care Products, announced the launch of a novel...Lincoln Pharmaceuticals wins patent for a Novel Nasal Drug delivery system introduces India's first Nasal Spray treatment for Vomiting!
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 17, 2011 titled "Lincoln Pharmaceuticals wins patent for a Novel Nasal Drug delivery system introduces India's first Nasal Spray treatment for Vomiting!"Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Digital Biotech Pvt Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSEDisclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Advent Tradelink Pvt Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSELincoln Pharmaceuticals Ltd. gains market share with technologically advanced Collagen Bio-tech products
Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release titled "Lincoln Pharmaceuticals Ltd. gains market share with technologically advanced Collagen Bio-tech products"Press Release :"Lincoln Pharmaceuticals Ltd. (LPL), a world class pharmaceutical company strengthens its position in the Indian pharmaceutical industry with its technologically advanced Collagen Bio-tech products, Medifil and Skin Temp. LPL tied-up with...Financial Results for Sep 30, 2010
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the Quarter ended September 30, 2010.Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Unichem Dyes & Drugs Pvt Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE